William Stohl

1. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
   2011/09/01 by Richard Furie, Michelle Petri, Omid Zamani +18 · 32 citations
   Medicine · #Systemic Lupus Erythematosus Research #Multiple Sclerosis Research Studies #Liver Diseases and Immunity
2. A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus
   2009/08/27 by Daniel J. Wallace, William Stohl, Richard A. Furie +16 · 3 citations
   Medicine · #Multiple Sclerosis Research Studies #Rheumatoid Arthritis Research and Therapies #Systemic Lupus Erythematosus Research